|
|
|
Insider
Information: |
Qvt Fund V Lp |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
187,957,104 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$1,634,224,503 |
|
|
Total
Shares |
187,957,104 |
|
|
Total
Value |
$1,634,224,503 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
2013-07-02 |
0 |
2013-09-30 |
11,712,953 |
Premium* |
|
Antigenics Inc |
AGEN |
10% Owner |
|
0 |
2015-01-09 |
6,915,630 |
Premium* |
|
Concert Pharmaceuticals, Inc. |
CNCE |
10% Owner |
2014-02-19 |
0 |
2014-02-19 |
559,999 |
Premium* |
|
Tekmira Pharmaceuticals Corp |
TKMR |
Director, 10% Owner |
|
0 |
2016-07-08 |
16,013,540 |
Premium* |
|
Sio Gene Therapies Inc |
SIOX |
10% Owner |
|
0 |
2018-06-05 |
89,285,714 |
Premium* |
|
Myovant Sciences Ltd. |
MYOV |
10% Owner |
|
0 |
2019-06-04 |
40,765,599 |
Premium* |
|
Urovant Sciences Ltd. |
UROV |
10% Owner |
2018-10-01 |
0 |
2018-10-01 |
22,703,669 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MYOV |
Myovant Sciences Ltd. |
10% Owner |
|
2019-06-04 |
4 |
B |
$8.25 |
$19,999,997 |
I/I |
2,424,242 |
40,765,599 |
1.5 |
- |
|
UROV |
Urovant Sciences Ltd. |
10% Owner |
|
2018-10-01 |
4 |
B |
$14.00 |
$37,499,994 |
I/I |
2,678,571 |
22,703,669 |
1.5 |
- |
|
SIOX |
Sio Gene Therapies Inc |
10% Owner |
|
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
I/I |
14,285,714 |
89,285,714 |
1.5 |
- |
|
MYOV |
Myovant Sciences Ltd. |
See Remarks |
|
2018-04-02 |
4 |
B |
$20.27 |
$22,500,004 |
I/I |
1,110,015 |
38,341,357 |
2.25 |
- |
|
MYOV |
Myovant Sciences Ltd. |
Director |
|
2016-10-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
37,231,342 |
|
- |
|
TKMR |
Tekmira Pharmaceuticals C... |
Director |
|
2016-07-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
16,013,540 |
|
- |
|
SIOX |
Sio Gene Therapies Inc |
10% Owner |
|
2016-07-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
75,000,000 |
|
- |
|
SIOX |
Sio Gene Therapies Inc |
10% Owner |
|
2015-06-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
75,000,000 |
|
- |
|
TKMR |
Tekmira Pharmaceuticals C... |
Director |
|
2015-03-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
16,013,540 |
|
- |
|
AGEN |
Antigenics Inc |
10% Owner |
|
2015-01-09 |
4 |
S |
$5.18 |
$12,451,322 |
I/I |
(2,343,630) |
6,915,630 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
10% Owner |
|
2014-02-19 |
4 |
B |
$14.00 |
$4,200,000 |
I/I |
300,000 |
559,999 |
1.5 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
10% Owner |
|
2014-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
259,999 |
259,999 |
0 |
- |
|
AGEN |
Antigenics Inc |
10% Owner |
|
2014-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,259,260 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-09-30 |
4 |
S |
$3.27 |
$9,566,807 |
I/I |
(2,754,900) |
11,712,953 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-08-09 |
4 |
B |
$6.37 |
$420,305 |
I/I |
65,982 |
14,467,853 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-08-08 |
4 |
B |
$6.48 |
$235,224 |
I/I |
36,300 |
14,401,871 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-07-11 |
4 |
B |
$6.46 |
$2,591,166 |
I/I |
401,017 |
14,365,571 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-07-10 |
4 |
B |
$6.35 |
$1,215,223 |
I/I |
190,944 |
13,964,554 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-07-09 |
4 |
B |
$6.30 |
$1,260,000 |
I/I |
200,000 |
13,773,610 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-07-08 |
4 |
B |
$6.30 |
$2,804,817 |
I/I |
445,209 |
13,573,610 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-07-05 |
4 |
B |
$6.21 |
$1,231,483 |
I/I |
197,300 |
13,128,401 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-07-03 |
4 |
B |
$6.24 |
$2,892,308 |
I/I |
463,248 |
12,931,101 |
1.5 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-07-02 |
4 |
B |
$6.30 |
$9,723,500 |
I/I |
1,500,000 |
12,467,853 |
1.5 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|